Retrophin

In honor of National Liver Awareness Month, join Retrophin patient advocacy for a live webinar about the impact of peroxisomal biogenesis disorder-Zellweger syndrome disorder (PBD-ZSD) on the liver. Dr. Jan Nogueira, Associate Professor of Pediatrics Division of Pediatric Gastroenterology, Hepatology and Nutrition at the Medical University of South Carolina, and ZSD Alliance member will be the keynote speaker. This 1-hour online presentation will include a Q&A session. Register at: https://bit.ly/3obKrpb

Committed to workplace excellence? Join Team Retrophin as a Senior Director, HRIS. View this and other #jobopportunities at https://bit.ly/2WBxuto.

Retrophin announces agreement to acquire Orphan Technologies. Read more at: https://bit.ly/2IWGUep

Our #KidneyWk 2020 Reimagined virtual exhibition booth is LIVE TODAY! We invite all members of #KidneyWk 2020 Reimagined to enter our Retrophin 3D interactive booth to learn more about focal segmental glomerulosclerosis (FSGS), IgA nephropathy (IgAN) and the impact of innovative endpoints in clinical trial design for these glomerular diseases. https://bit.ly/37DSPYC

The Retrophin-sponsored virtual Exhibitor Spotlight session at #KidneyWk 2020 Reimagined, October 2025, titled Understanding innovative endpoints in glomerular diseases is LIVE TODAY, available to all virtual members of #KidneyWk 2020 Reimagined. https://bit.ly/3ohObWk

We are excited to be part of an effort to kickstart a reimagining of how society approaches rare kidney disease education and care, said Eric Dube, chief executive officer of Retrophin. Learn more about a collaboration between NephCure Kidney International and Retrophin, in partnership with the American Association of Kidney Patients, to usher in a new era of rare kidney disease care. Read the press release: https://prn.to/2Hp21Wj

Make an impact for those living with rare disease. Join team Retrophin as a Director, Genetic Epidemiology. View this and other #jobopportunities at https://bit.ly/2WBxuto. #hiring #Epidemiology

Pursuing bold science. Imagining what’s possible. At Retrophin, this is what drives our innovation in clinical trials for glomerular diseases such as focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN). At #KidneyWk 2020 Reimagined, October 2025, we invite you to view the Retrophin-sponsored virtual Exhibitor Spotlight session titled Understanding innovative endpoints in glomerular diseases, available to all virtual members of #KidneyWk 2020 Reimagined. https://bit.ly/3iJnhmo

The Chair of the upcoming Retrophin-sponsored virtual Exhibitor Spotlight session at #KidneyWk 2020 Reimagined, October 2025, Dr. Jonathan J. Hogan, invites all virtual members of #KidneyWk 2020 Reimagined to view the session, which will be available to view until December 4.

At Retrophin, we know that the journey of each person living with a rare disease is unique. Our CEO, Eric Dube, Ph.D., recently spoke with nephrotic syndrome advocacy group NephCure Kidney International to explain his own unique perspective on the role Retrophin is playing to help rare kidney patients along the way. Learn more below:

Looking for Retrophin at this week’s National Organization for Rare Disorders, Inc. (NORD)'s #NORDSummit? Catch up with CEO Eric Dube, Ph.D., at the Diversity and Inclusion in the Rare Community Panel Friday, October 9, starting at 9:45 a.m. PT / 12: 45 p.m. ET. There’s still time to register at: https://rarediseases.org/summit-overview #RetrophinRare

Retrophin is hiring! Join our team as a Clinical Operations Associate or Clinical Compliance Specialist. View these and other open positions at https://bit.ly/2WBxuto. #hiring #ClinicalOperations #ClinOps